AI-generated summary
The authors report on 40 adolescents with disseminated pulmonary tuberculosis, of whom 19 received supravenous blood laser radiation 2 to 3 weeks after starting chemotherapy as part of their treatment. In this group, the authors report that the laser therapy was associated with faster positive changes, by 2.5 to 3.5 months, based on clinical and laboratory measures, and with less pronounced residual lung changes.
- Participants
- 40
- Who or what was studied
- Adolescent patients with disseminated pulmonary tuberculosis
- Limits stated in the abstract
- The abstract does not describe the study design, control group, or how patients were allocated to laser treatment, so the findings cannot be attributed to the laser alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.